EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

In vivo synergistic tumor therapies based on copper sulfide photothermal therapeutic nanoplatforms

Jingwen Ma iD, Na Li, Jingjian Wang, Zhe Liu, Yulong Han, Yun Zeng iD

Exploration · 2023-10 · 3 (5)

DOI: 10.1002/exp.20220161 ↗

At a glance

Übersichtsarbeit in Exploration, published online on 2023-06-24. Written by Jingwen Ma and 5 co-authors. Institution: Radiology Department CT and MRI Room Ninth Hospital of Xi'an Ninth Affiliated Hospital of Medical College of Xi'an Jiaotong University Xi'an Shaanxi …. Cited 150 times so far (Crossref); 126 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Tumor cells may be eliminated by increasing their temperature. This is achieved via photothermal therapy (PTT) by penetrating the tumor tissue with near‐infrared light and converting light energy into heat using photothermal agents. Copper sulfide nanoparticles (CuS NPs) are commonly used as PTAs in PTT. In this review, we aimed to discuss the synergism between tumor PTT with CuS NPs and other therapies such as chemotherapy, radiotherapy, dynamic therapies (photodynamic, chemodynamic, and sonodynamic therapy), immunotherapy, gene therapy, gas therapy, and magnetic hyperthermia. Furthermore, we summarized the results obtained with a combination of two treatments and at least two therapies, with PTT as one of the included therapies. Finally, we summarized the benefits and drawbacks of various therapeutic options and state of the art CuS‐based PTT and provided future directions for such therapies.

Subjects

Author keywords

copper sulfidephotothermal therapysynergistic therapytumor treatment

Authors and institutions

  • Radiology Department CT and MRI Room Ninth Hospital of Xi'an Ninth Affiliated Hospital of Medical College of Xi'an Jiaotong University Xi'an Shaanxi Province P. R. China.
  • Department of Pathology Ninth Hospital of Xi'an Ninth Affiliated Hospital of Medical College of Xi'an Jiaotong University Xi'an Shaanxi Province P. R. China.
  • School of Engineering and Applied Sciences Harvard University Cambridge Massachusetts USA.
  • School of Life Science and Technology Xidian University and Engineering Research Center of Molecular and Neuro Imaging, Ministry of Education Xi'an Shaanxi Province P. R. China.
  • International Joint Research Center for Advanced Medical Imaging and Intelligent Diagnosis and Treatment and Xi'an Key Laboratory of Intelligent Sensing and Regulation of trans-Scale Life Information, School of Life Sci…

ORCID profiles: Jingwen Ma, Yun Zeng

Funding

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities

Cite

APA

Ma, J., Li, N., Wang, J., Liu, Z., Han, Y., & Zeng, Y. (2023). In vivo synergistic tumor therapies based on copper sulfide photothermal therapeutic nanoplatforms. Exploration, 3(5). https://doi.org/10.1002/exp.20220161

Vancouver

Ma J, Li N, Wang J, Liu Z, Han Y, Zeng Y. In vivo synergistic tumor therapies based on copper sulfide photothermal therapeutic nanoplatforms. Exploration. 2023;3(5). doi:10.1002/exp.20220161

BibTeX
@article{Ma2023,
  author = {Ma, Jingwen and Li, Na and Wang, Jingjian and Liu, Zhe and Han, Yulong and Zeng, Yun},
  title = {In vivo synergistic tumor therapies based on copper sulfide photothermal therapeutic nanoplatforms},
  journal = {Exploration},
  year = {2023},
  volume = {3},
  number = {5},
  doi = {10.1002/exp.20220161}
}
Start for free →